✦ LIBER ✦

The tandem mass spectrometry newborn screening experience in North Carolina: 1997–2005

✍ Scribed by D. M. Frazier; D. S. Millington; S. E. McCandless; D. D. Koeberl; S. D. Weavil; S. H. Chaing; J. Muenzer

Publisher: Springer
Year: 2006
Tongue: English
Weight: 255 KB
Volume: 29
Category: Article
ISSN: 0141-8955
DOI: 10.1007/s10545-006-0228-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Making the case for objective performanc

Making the case for objective performance metrics in newborn screening by tandem mass spectrometry

✍ Rinaldo, Piero ;Zafari, Saba ;Tortorelli, Silvia ;Matern, Dietrich 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 256 KB

## Abstract The expansion of newborn screening programs to include multiplex testing by tandem mass spectrometry requires understanding and close monitoring of performance metrics. This is not done consistently because of lack of defined targets, and interlaboratory comparison is almost nonexistent

Direct multiplex assay of enzymes in dri

Direct multiplex assay of enzymes in dried blood spots by tandem mass spectrometry for the newborn screening of lysosomal storage disorders

✍ Michael H. Gelb; Frantisek Turecek; C. Ron Scott; Nestor A. Chamoles 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 335 KB

In vivo pharmacokinetic screening in cas

In vivo pharmacokinetic screening in cassette dosing experiments: the use of on-line prospekt® liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry technology in drug discovery

✍ Francis Beaudry; J. C. Yves Le Blanc; Michel Coutu; Nigel K. Brown 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB 👁 2 views

Drug discovery is a fast growing field and the number of compounds generated daily by the pharmaceutical industry is enormous. The necessity of developing new experimental strategies and analytical methods to rapidly screen the pharmacokinetics (PK) behavior of these compounds becomes a real challen